RxDoctor Payments Data

Christy Lowrance

Physician Assistant · Beaumont, TXNPI 1538294913

Payments from drug & device makers

$7,243in general payments, 2019–2025

Across 377 payments — averaging $19.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$2K
  • Abbott$781
  • Novartis$609
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$569
  • Merck$457
  • Johnson & Johnson$382
  • plus $2K from 23 others

What the payments were for

  • Travel & lodging$5458%
  • Food & beverage$6,68792%
  • Education$110%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,243 in reported general payments places this provider in the 90th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban763$769,504
XareltoRivaroxaban309$282,181
EntrestoSacubitril/Valsartan242$242,319
Repatha SureclickEvolocumab137$114,585
Praluent PenAlirocumab50$30,460
VascepaIcosapent Ethyl49$28,082
JardianceEmpagliflozin31$26,644
OzempicSemaglutide25$25,808
Repatha SyringeEvolocumab15$17,514
MultaqDronedarone Hcl12$12,933
Icosapent Ethyl36$12,383
CorlanorIvabradine Hcl24$11,368
Rosuvastatin Calcium604$8,959
Metoprolol Succinate433$5,942
Dabigatran EtexilateDabigatran Etexilate Mesylate15$5,155

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$171$769,504763 claims
Johnson & JohnsonXarelto$382$282,181309 claims
NovartisEntresto$609$242,319242 claims
Boehringer IngelheimJardiance$181$26,64431 claims
Novo NordiskOzempic$98$25,80825 claims
Sanofi-aventis U.S. LLCMultaq$52$12,93312 claims
AmgenCorlanor$81$11,36824 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Beaumont

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →